Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

AOU Careggi – AOU Meyer Consortium, Firenze, Italy

In this page

How to contact the center

Full member

HCP Center

Careggi University Hospital – HCP (the largest polyclinic Hospital in Florence) is one of the main Hospital in Italy. The HCP provides the management of the most significant rare eye disorders (inherited retinal and choroidal dystrophies), keratoconus, corneal dystrophies, and inherited optic neuropathies. The patients are referred by the peripheral structures of the National Health Services (local Clinics and Hospitals).

Picture : Sailko, Wikimedia Commons

Contact

AOU Careggi – AOU Meyer Consortium, Firenze, Italy

Largo Brambilla 3
50134 Florence
Italy

Team

Dr Fabrizio Giansanti

Representative
See more

Dr Giacomo Maria Bacci

Substitute

Italy

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
See more

Dr Pina Fortunato

Italy

Pediatric Ophthalmology Rare Diseases (WG3)
See more

Dr Sara Bargiacchi

Italy

Pediatric Ophthalmology Rare Diseases (WG3)
See more

Dr Andrea SODI

Italy

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Retinal Rare Eye Diseases (WG1)
See more

Dr Dario Pasquale Mucciolo

Italy

Pediatric Ophthalmology Rare Diseases (WG3)
See more

Dr Vittoria Murro

Italy

Pediatric Ophthalmology Rare Diseases (WG3)
See more

Clinical trials

NCT04671433 - Active, Not recruiting

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04794101 - Active, Not recruiting

Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche

NCT04525261 - Completed

Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene

Observational
See the trial
voir la fiche
NCT02771379 - Completed

A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).

Observational
See the trial
voir la fiche
NCT03364153 - Active, Not recruiting

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Interventional
See the trial
voir la fiche
NCT04435366 - Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT04276558 - Recruiting, Active

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Interventional
See the trial
voir la fiche
NCT01756456 - Completed

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Interventional
See the trial
voir la fiche
NCT04088409 - Active, Not recruiting

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Interventional
See the trial
voir la fiche